Food
Fresh, frozen, and processed poultry for households.
Why it matters · Salmonella and Listeria recalls can pull common products from retail shelves with little warning.
3
Inputs
14
Companies
15
Facilities
10
Source countries
How it's made
Primary Breeding / Grandparent Flock
Two companies (Aviagen, Cobb-Vantress) maintain closed pedigree great-grandparent lines evaluated on 200,000+ data points per bird. Pure lines are never sold commercially; only progeny are licensed. Disrupting this tier has 9–18 month propagation lag through the breeding pyramid to commercial birds.
Hatchery & Day-Old Chick Placement
Fertile eggs from parent flocks incubated 21 days. On hatch day, chicks are sexed, vaccinated in-ovo or at hatch (Marek's disease, Newcastle disease), and placed at integrator-owned or contracted grow-out farms within hours. Each chick receives a dose of Marek's vaccine without which it would succumb to hyperpathogenic MDV within weeks.
Grow-Out (Contract Grower Farm)
Day-old chicks placed in tunnel-ventilated broiler houses. Integrator supplies chicks, feed (methionine-supplemented corn-soy), medications, and technical supervision. Growers supply housing and labor. Grow-out: 5–7 weeks to 6–9 lbs live weight. Feed conversion ratio (~1.8 lbs feed per lb gain) is the primary payment metric.
Live Haul & Ante-Mortem Inspection
Catching crews load birds into transport crates. Birds trucked typically 30–50 miles to the processing complex. USDA FSIS inspectors perform ante-mortem inspection at the plant.
Slaughter, Defeathering & Evisceration
Electrical stunning → bleed → scalding → automated defeathering → evisceration → USDA post-mortem inspection. Ammonia refrigeration (anhydrous NH₃, R-717) cools carcasses to ≤40°F internal temperature as required by USDA 9 CFR 381.66. Processing plants use 5–7+ gallons of water per bird.
Cut-Up, MAP Packaging & Cold Chain Distribution
Whole carcasses cut into parts (breast, thigh, wing, drumstick). Fresh retail cuts packaged in modified atmosphere (0% O₂ / 30% CO₂ / 70% N₂) to inhibit Pseudomonas spoilage, extending shelf life from 2–4 days to 5–8 days at 37°F. Distributed via cold chain to retail within 24–72 hours.
What it's made of
3 raw inputs feed chicken and turkey. Inputs flagged with ● are critical, without them, production halts.
Where it comes from
Weighted share of upstream inputs sourced from each country.
| Country | Weighted share | Inputs supplied to chicken and turkey |
|---|---|---|
| USUnited States | 37% | Day-Old Broiler Chick (Genetics) · DL-Methionine / HMTBa (Feed-Grade) · Marek's Disease Vaccine (MDV) |
| CNChina | 18% | Day-Old Broiler Chick (Genetics) · DL-Methionine / HMTBa (Feed-Grade) · Marek's Disease Vaccine (MDV) |
| GBUnited Kingdom | 17% | Day-Old Broiler Chick (Genetics) · Marek's Disease Vaccine (MDV) |
| SGSingapore | 17% | DL-Methionine / HMTBa (Feed-Grade) |
| JPJapan | 12% | DL-Methionine / HMTBa (Feed-Grade) |
| NLNetherlands | 9% | Day-Old Broiler Chick (Genetics) · Marek's Disease Vaccine (MDV) |
| FRFrance | 8% | Day-Old Broiler Chick (Genetics) · DL-Methionine / HMTBa (Feed-Grade) · Marek's Disease Vaccine (MDV) |
| BRBrazil | 8% | Day-Old Broiler Chick (Genetics) |
| BEBelgium | 6% | DL-Methionine / HMTBa (Feed-Grade) |
| MYMalaysia | 4% | DL-Methionine / HMTBa (Feed-Grade) |
Who makes it
14 companies in this supply chain, sorted by market share.
Broiler genetics company owned by Hendrix Genetics (Dutch) since 2022 acquisition from Tyson Foods (~$1B). Cobb 500 breed represents ~46-50% of all globally farmed broilers. Together with Aviagen/Ross, controls ~90% of global commercial broiler genetics.
Supplies these inputs
Day-Old Broiler Chick (Genetics)
Replaceability
Substitutability 20% · 18 mo to replace
Business segments
Aviagen Group (Huntlywood, Midlothian, Scotland; wholly owned subsidiary of EW Group GmbH, Germany; formed by EW Group in 2002 from merger of Ross Breeders and Arbor Acres) is the world's largest broiler (chicken meat) genetics company — producing the Ross 308 and Ross 708 broiler breeds that together dominate global broiler production. Aviagen is noted here primarily because it is a co-subsidiary of EW Group alongside Hy-Line and Lohmann — meaning the same German family (Wesjohann/EW Group) controls dominant genetics for eggs (Hy-Line + Lohmann), chicken meat (Aviagen Ross), and turkey (British United Turkeys). Aviagen has limited layer operations (through its Lohmann sister company under EW Group). The combined EW Group poultry genetics portfolio — Hy-Line layers + Lohmann layers + Aviagen broilers — constitutes the most concentrated position in global food supply genetics in existence. No government has subjected EW Group's dual egg-and-meat genetics dominance to antitrust scrutiny.
Supplies these inputs
Day-Old Broiler Chick (Genetics)
Replaceability
Substitutability 20% · 18 mo to replace
Business segments
Global leader in Marek's disease vaccine production and the world's largest producer of poultry vaccines. Its Gainesville, Georgia facility produces approximately 60 billion poultry vaccine doses per year for the US and ~60 other countries — one of the largest single biological manufacturing sites in the world. In 2024, acquired Elanco's US poultry biologics portfolio for $885M, further consolidating leadership. Product portfolio includes HVT-based vaccines, PREVEXXION RN (chimeric Serotype 1, first new MDV1 innovation in 40+ years, approved EU/UK 2021), and the VAXXITEK recombinant HVT vector family. Also a major human pharmaceutical company (Jardiance, Pradaxa, Spiriva, Dupixent collaborator).
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 40% · 12 mo to replace
Business segments
Global animal nutrition subsidiary of China National BlueStar Group; world's second-largest methionine producer (~25% global share). Operates Nanjing plant (~350,000 MT/yr DL-Met + 180,000 MT/yr liquid methionine). Key products: Rhodimet NP99, Smartamine, Rhodimet AT88.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 35% · 6 mo to replace
Business segments
Merck Animal Health (Madison NJ; division of Merck & Co.; ~$5.5B revenue) manufactures AviPro brand avian influenza and Newcastle disease vaccines for commercial poultry. Products sold as MSD Animal Health outside North America. Merck Animal Health is the third-largest animal health company globally. De Soto KS biologics manufacturing site.
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 42% · 12 mo to replace
Business segments
Evonik Industries AG (XETRA: EVK; Essen Germany; MDAX listed); world's largest DL-methionine producer under the MetAMINO brand. Total DL-methionine capacity exceeds 700,000 MT/year across three continental hubs: Jurong Island Singapore (~340,000 MT/year — world's largest single methionine complex, expanded +40k MT August 2024), Theodore Mobile County Alabama USA (~245,000 MT/year), and Antwerp Belgium (~120,000 MT/year). The Wesseling Germany DL-Met line closed Q1 2021 as Evonik consolidated production to the three-hub network. Evonik first commercialized DL-methionine synthesis in the 1950s under predecessor Degussa. MetAMINO is Evonik's largest single product. ~30-32% global market share. In February 2022 Evonik announced a $176.5M investment in a new methyl mercaptan (MMP intermediate feedstock) plant at the Alabama site.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 30% · 6 mo to replace
Business segments
Ceva Santé Animale (Libourne, France; private; ~€1.7B revenue) is the 5th largest animal health company globally and a major poultry vaccine manufacturer. Ceva produces MAFIVAC AI vaccines, VECTORMUNE ND+AI recombinant vaccines, and other poultry biologicals. Ceva has significant manufacturing in France (Libourne + Pau), Spain, and the US. In 2022-2024, Ceva supplied emergency AI vaccines to France's commercial duck industry during HPAI H5N1 outbreaks.
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 42% · 10 mo to replace
Business segments
Sumitomo Chemical Co. Ltd. (Tokyo Japan; TYO: 4005; Sumitomo Group); #3 global DL-methionine producer at ~13% market share via Niihama Ehime Works (Ehime Prefecture Shikoku Japan). After a major expansion completed October 2018 (+100,000 MT/year new line), the Niihama facility reached ~250,000 MT/year — one of the world's largest single methionine plants. Also produces crop protection chemicals (agrichemicals), petrochemicals, and pharmaceuticals. The MetiPEARL / liquid methionine brand competes directly with Evonik MetAMINO and Adisseo Rhodimet in Asian poultry markets. Japan is the only significant Japanese methionine production base globally.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 32% · 9 mo to replace
Business segments
Novus International (Chesterfield / St. Charles MO USA; owned 80% Mitsui & Co. Japan + 20% Nippon Soda Japan); global animal nutrition company producing ALIMET (HMTBa — 2-hydroxy-4-(methylthio)butanoic acid), a liquid methionine hydroxy analog that is approved as bioequivalent to DL-methionine in poultry and swine diets. ALIMET plant at Chocolate Bayou TX near Alvin Brazoria County (~284,000 MT/year nameplate capacity; first shipment 1984). Also produces MFP (Methionine Feed Grade Powder) and gut health products. ~10-15% global methionine market share. Note: ALIMET is an analog (not identical to dry DL-methionine) — approved by FDA and EU for equivalent nutritional use in poultry. US-based production is Japanese-owned, not American-owned. Revenue ~$650M/year.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 35% · 8 mo to replace
Business segments
Guangdong-based animal biologics subsidiary of Wens Group (one of China's largest poultry integrators). Holds production licenses for 50+ vaccine products including MDV vaccines for China's domestic poultry market — the world's largest single-country chicken industry (~15 billion birds/year). Not a significant exporter to regulated Western markets. Emblematic of China's strategy to develop domestic poultry biological capabilities, particularly relevant given Chinese hypervirulent MDV strains (vv+MDV) that are challenging all current commercial vaccines.
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 45% · 6 mo to replace
Business segments
Zoetis Inc. (NYSE: ZTS; ~$8.5B revenue; Parsippany NJ) is the world's largest animal health company, spun off from Pfizer in 2013. Zoetis manufactures TROVAC-NDV and conventional inactivated AI vaccines for commercial poultry, along with broad-spectrum animal health products for livestock and companion animals across 100 countries.
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 45% · 10 mo to replace
Business segments
Chinese specialty chemicals company (Shenzhen-listed); the most significant new entrant in the global methionine market. Started commercial production of a 150,000 MT/year DL-methionine line in October 2023 (after delaying from the planned June 2023 start due to the 2023 methionine price crash). NHU's entry was a key catalyst for the 2023 global methionine oversupply event that cut prices roughly in half from COVID-era peaks. Also produces vitamins (Vitamin E, Vitamin A) — the company is a major factor in multiple feed additive markets simultaneously.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 40% · 6 mo to replace
Business segments
Phibro Animal Health Corporation (Teaneck NJ; NASDAQ: PAHC; ~$1B revenue) manufactures POULVAC brand poultry vaccines (acquired from Fort Dodge/Zoetis divestiture) along with medicated feed additives and nutritional products. Phibro serves commercial poultry producers globally with AI vaccines, Newcastle disease biologics, and coccidiostats.
Supplies these inputs
Marek's Disease Vaccine (MDV)
Replaceability
Substitutability 48% · 8 mo to replace
Business segments
CJ CheilJedang Corporation (Seoul South Korea; KRX: 097950; subsidiary of CJ Group); South Korean food and bio conglomerate; world's largest L-lysine producer (~25% global share) via fermentation biotechnology. Operates the world's first and only commercial-scale bio-based L-methionine facility at Kertih Biopolymer Park Terengganu Malaysia (80,000 MT/year; opened 2015 using genetically engineered E. coli K-12 fermenting plant sugars — producing L-methionine rather than racemic DL-methionine). CJ's fermentation-route L-methionine is chemically distinct from synthetic DL-methionine but is approved as nutritionally equivalent in poultry diets. Also produces tryptophan, threonine, and other feed amino acids globally. Pet food market interest in fermentation-derived (non-petrochemical) amino acids is growing.
Supplies these inputs
DL-Methionine / HMTBa (Feed-Grade)
Replaceability
Substitutability 40% · 10 mo to replace
Business segments
Where it's made
15 facilities producing inputs that feed chicken and turkey.
Adisseo (Bluestar Adisseo Nutrition Group) · Nanjing, Jiangsu · amino acid manufacturing
Adisseo's primary production site; ~350,000 MT/yr DL-methionine plus 180,000 MT/yr liquid methionine (HMTBa analog) operational since 2022. Major concentration of global methionine capacity in a single Chinese industrial city; trade policy or regulatory disruption here would propagate immediately to global poultry costs.
Aviagen Group · Huntsville, Alabama · poultry genetics nucleus breeding
Global headquarters and one of Aviagen's primary nucleus biosecurity facilities where pure pedigree GGP lines are maintained. Access restricted; no commercial birds are sold from GGP lines. An HPAI introduction or biosecurity breach here would require months of restocking from isolated backup lines.
Boehringer Ingelheim Animal Health · Gainesville, Hall County, Georgia · pharmaceutical_plant
World's largest single-site poultry vaccine manufacturing facility; produces approximately 60 billion doses per year for the US and ~60 other countries. First BI Animal Health US site to be certified carbon neutral (2022). Produces HVT-based monovalents, bivalents, recombinant HVT vector vaccines (VAXXITEK), and PREVEXXION RN. 60 billion doses/year from one facility represents an extraordinary concentration — an event (natural disaster, pandemic shutdown, fire, contamination) at this single Georgia location would immediately affect global MDV vaccine supply for both the US and 60 export countries.
CJ CheilJedang Corporation · Kertih Biopolymer Park, Terengganu · fermentation
World's first and only commercial-scale bio-based L-methionine plant; 80,000 MT/year capacity; opened early 2015. CJ uses genetically engineered E. coli K-12 fermenting plant sugars — produces L-methionine (single enantiomer) rather than racemic DL-methionine of chemical synthesis. Arkema co-located a thiochemicals (methyl mercaptan) plant at the same Kertih site as feedstock supplier. Fermentation-derived L-methionine is valued by premium pet food and organic poultry segments seeking non-petrochemical amino acids.
Ceva Santé Animale · Libourne, Gironde · pharmaceutical_plant
Ceva's global headquarters and a major production site for poultry biologics including CEVAC MD Rispens and bivalent MDV vaccines. Ceva claims the original European Rispens lineage. Libourne, near Bordeaux, is the nerve center of a poultry vaccine company that punches above its weight given its market focus specialization on poultry biologics vs. the diversified multinational competitors.
Cobb-Vantress, Inc. · Siloam Springs, Arkansas · poultry genetics and hatchery
Global headquarters of Cobb-Vantress; primary US research and pedigree nucleus for the Cobb 500 and Cobb 700 broiler lines. Siloam Springs is also in the heart of the US broiler belt (Arkansas/NW Arkansas region hosts Tyson corporate HQ). Concentrated genetics and corporate infrastructure in a single region.
Evonik Industries AG · Antwerp, Belgium · chemical_plant
Evonik's European DL-methionine production hub (~120,000 MT/year). Fed by MMP (methylmercaptopropanal) intermediate from Evonik Wesseling, Germany. Evonik's Wesseling site closed its DL-methionine production line in Q1 2021 but continues as an intermediates-only site with a €25M-upgraded MMP plant (announced January 2023) supplying the Antwerp finishing plant.
Evonik Industries AG · Jurong Island · amino acid manufacturing
World's largest single-site methionine production facility; expanded to 340,000 MT/yr DL-methionine capacity in 2024 after NZD $500M+ investment. Located on Jurong Island petrochemical hub. Serves Asia-Pacific demand for broiler, layer, and swine feed supplements.
Evonik Industries AG · Theodore, Mobile County, Alabama · chemical_plant
Evonik's Americas DL-methionine hub at Theodore, Mobile County, Alabama (~245,000 MT/year capacity). In February 2022 Evonik announced a $176.5M investment to build a new methyl mercaptan (MMP intermediate) plant at this site, reducing Antwerp import dependency and cutting CO₂ footprint ~7%. This is one of only two methionine production sites in the Western Hemisphere (the other is Novus's Chocolate Bayou, TX site).
Guangdong Wens Dahuanong Biotechnology · Yunfu, Guangdong · pharmaceutical_plant
Primary production site for China's domestic MDV vaccine market. China produces ~15 billion chickens/year and has unique MDV pressure from hypervirulent vv+ strains circulating in Henan and Shandong provinces that breach protection from Western vaccines. Chinese domestic vaccine producers serve this market but are not exported to regulated Western hatcheries.
Merck Animal Health (MSD Animal Health) · Boxmeer, North Brabant · pharmaceutical_plant
Merck/MSD Animal Health primary European production facility and the birthplace of CVI988/Rispens — the 'gold standard' MDV vaccine strain developed at the Central Veterinary Institute in the Netherlands and described by Rispens et al. in 1972. Produces RISMAVAC (frozen CVI988 Rispens, stored below -150°C) and INNOVAX recombinant HVT vector vaccines. The Netherlands' historical role in Rispens development means Boxmeer holds irreplaceable institutional knowledge for this critical vaccine strain.
NHU Group · Xinchang, Zhejiang · chemical_plant
NHU's 150,000 MT/year DL-methionine plant; started trial production August 2023, commercial October 2023 (after delaying from June 2023 target due to price crash). NHU's entry was the primary catalyst for the 2023 global methionine price crash — prices fell from COVID-era peaks above $5,000/MT to ~$2,700/MT by December 2023. NHU also produces vitamins E and A from the same Xinchang complex, making it a multi-feed-additive producer simultaneously.
Novus International · Chocolate Bayou, near Alvin, Brazoria County, Texas · chemical_plant
Novus's primary ALIMET (HMTBa liquid methionine analog) manufacturing plant; first shipment 1984; ~284,000 MT/year nameplate capacity. Owned 80% by Mitsui & Co. (Japan) and 20% by Nippon Soda (Japan) — the plant is Japanese-owned, not Chinese-owned. ALIMET is 2-hydroxy-4-(methylthio)butanoic acid — a liquid methionine hydroxy analogue, chemically distinct from dry DL-methionine. Located on the Gulf Coast for easy petrochemical feedstock access and port export.
Sumitomo Chemical Co., Ltd. · Niihama, Ehime Prefecture · chemical_plant
Sumitomo Chemical's sole DL-methionine facility; ~250,000 MT/year after 2018 expansion (+100,000 MT/yr new line, completion ceremony October 2018). One of the largest single capital investments ever at Ehime Works. Sumitomo is the #3 global DL-methionine producer by capacity at ~13% global market share. Niihama is a legacy chemical complex with facilities dating to the 1930s.
Zoetis Inc. · Kalamazoo, Michigan · pharmaceutical_plant
Zoetis US production hub for poultry biologics including MD-Vac CFL (cell-free HVT) and POULVAC PROCERTA HVT-IBD-ND (launched October 2022). The Kalamazoo facility is the legacy of Pfizer Animal Health's manufacturing footprint, inherited when Zoetis spun off from Pfizer in 2013.
